• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依那西普治疗中毒性表皮坏死松解症。

Etanercept therapy for toxic epidermal necrolysis.

机构信息

Health Services Research Unit, IDI-IRCCS, Rome, Italy.

Health Services Research Unit, IDI-IRCCS, Rome, Italy.

出版信息

J Am Acad Dermatol. 2014 Aug;71(2):278-83. doi: 10.1016/j.jaad.2014.04.044. Epub 2014 Jun 11.

DOI:10.1016/j.jaad.2014.04.044
PMID:24928706
Abstract

BACKGROUND

Toxic epidermal necrolysis (TEN) is a severe and potentially lethal drug reaction for which no standard treatment is available.

OBJECTIVE

To describe a case series of patients with TEN treated with a single dose of etanercept.

METHODS

We observed 10 consecutive patients with TEN. For each patient, we recorded the presence of comorbidities and all the drugs recently started (ie, in the last month). In all cases, 50 mg of etanercept was administered in a single subcutaneous injection. The clinical severity of disease was computed using the SCORe of Toxic Epidermal Necrosis (SCORTEN) scale. Using the probabilities of death linked to each level of SCORTEN score, we calculated the expected probability of death in our patients. Healing was defined as complete reepithelialization, and a time to healing curve was then obtained using the Kaplan-Meier method.

RESULTS

All patients promptly responded to treatment, reaching complete reepithelialization without complications or side effects. The median time to healing was 8.5 days.

LIMITATIONS

This is a small, uncontrolled case series.

CONCLUSION

These preliminary results suggest the possibility that tumor necrosis factor-alfa may be an effective target for control of TEN, a dangerous skin condition for which no effective cure has yet been found.

摘要

背景

中毒性表皮坏死松解症(TEN)是一种严重且潜在致命的药物反应,目前尚无标准治疗方法。

目的

描述一组接受依那西普单次剂量治疗的 TEN 患者的病例系列。

方法

我们观察了 10 例连续的 TEN 患者。对于每位患者,我们记录了合并症的存在情况以及最近开始使用的所有药物(即在过去一个月内)。在所有情况下,均给予 50mg 依那西普单次皮下注射。使用毒性表皮坏死评分(SCORTEN)量表计算疾病的临床严重程度。根据与 SCORTEN 评分每个水平相关的死亡概率,我们计算了我们患者的预期死亡概率。愈合定义为完全再上皮化,并使用 Kaplan-Meier 方法获得愈合时间曲线。

结果

所有患者均迅速对治疗产生反应,无并发症或副作用,完全再上皮化。中位愈合时间为 8.5 天。

局限性

这是一项小型、非对照的病例系列研究。

结论

这些初步结果表明,肿瘤坏死因子-α可能是控制 TEN 的有效靶点,TEN 是一种危险的皮肤疾病,目前尚无有效的治疗方法。

相似文献

1
Etanercept therapy for toxic epidermal necrolysis.依那西普治疗中毒性表皮坏死松解症。
J Am Acad Dermatol. 2014 Aug;71(2):278-83. doi: 10.1016/j.jaad.2014.04.044. Epub 2014 Jun 11.
2
A new case series on etanercept treatment for toxic epidermal necrolysis.关于依那西普治疗中毒性表皮坏死松解症的新病例系列。
Eur J Dermatol. 2020 Oct 1;30(5):561-568. doi: 10.1684/ejd.2020.3883.
3
Toxic epidermal necrolysis successfully treated with etanercept.用依那西普成功治疗中毒性表皮坏死松解症。
J Dermatol. 2009 Mar;36(3):150-3. doi: 10.1111/j.1346-8138.2009.00616.x.
4
Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus successfully treated with a single dose of etanercept: report of three cases.单剂量依那西普成功治疗中毒性表皮坏死松解症样急性皮肤型红斑狼疮:三例报告
J Am Acad Dermatol. 2013 Dec;69(6):e303-5. doi: 10.1016/j.jaad.2013.07.036.
5
Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.静脉注射免疫球蛋白与糖皮质激素联合治疗中毒性表皮坏死松解症和史蒂文斯-约翰逊综合征:中国的一项回顾性对照研究
Int J Dermatol. 2009 Oct;48(10):1122-8. doi: 10.1111/j.1365-4632.2009.04166.x.
6
Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.新加坡一家综合医院中 Stevens-Johnson 综合征和中毒性表皮坏死松解症的特征和模式:治疗结果。
Acta Derm Venereol. 2012 Jan;92(1):62-6. doi: 10.2340/00015555-1169.
7
Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症的眼部表现及其与 SCORTEN 的关系。
Am J Ophthalmol. 2010 Oct;150(4):505-510.e1. doi: 10.1016/j.ajo.2010.04.026. Epub 2010 Jul 8.
8
High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases.大剂量静脉注射免疫球蛋白治疗中国史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症患者的回顾性研究:82 例病例报告。
Eur J Dermatol. 2010 Nov-Dec;20(6):743-7. doi: 10.1684/ejd.2010.1077. Epub 2010 Oct 15.
9
Dexamethasone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis.地塞米松脉冲疗法治疗史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症。
Acta Derm Venereol. 2007;87(2):144-8. doi: 10.2340/00015555-0214.
10
Prognostic value of histologic features of toxic epidermal necrolysis.中毒性表皮坏死松解症组织学特征的预后价值。
J Am Acad Dermatol. 2013 Feb;68(2):e29-35. doi: 10.1016/j.jaad.2011.10.007. Epub 2011 Nov 16.

引用本文的文献

1
The case for etanercept in the management of toxic epidermal necrolysis.依那西普在中毒性表皮坏死松解症治疗中的应用依据
Skin Health Dis. 2025 May 28;5(4):247-255. doi: 10.1093/skinhd/vzaf012. eCollection 2025 Aug.
2
Feedback regulation of VISTA and Treg by TNF-α controls T cell responses in drug allergy.肿瘤坏死因子-α对VISTA和调节性T细胞的反馈调节控制药物过敏中的T细胞反应。
Allergy. 2025 May;80(5):1400-1416. doi: 10.1111/all.16393. Epub 2024 Nov 11.
3
Effect of Early Cyclosporine Treatment on Survival in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
早期环孢素治疗对史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症患者生存率的影响。
Cureus. 2024 Apr 8;16(4):e57862. doi: 10.7759/cureus.57862. eCollection 2024 Apr.
4
Retrospective evaluation of a TEN/SJS series managed with a new treatment protocol.对采用新治疗方案管理的一组中毒性表皮坏死松解症/重症多形红斑病例进行回顾性评估。
J Eur Acad Dermatol Venereol. 2025 Jan;39(1):e42-e45. doi: 10.1111/jdv.20060. Epub 2024 May 7.
5
Severe cutaneous adverse reactions.严重皮肤不良反应。
Nat Rev Dis Primers. 2024 Apr 25;10(1):30. doi: 10.1038/s41572-024-00514-0.
6
Efficacy of borneol-gypsum in skin regeneration and pain control in toxic epidermal necrolysis: A case report.冰片石膏在中毒性表皮坏死松解症皮肤再生和疼痛控制中的疗效:一例报告
World J Clin Cases. 2024 Mar 6;12(7):1290-1295. doi: 10.12998/wjcc.v12.i7.1290.
7
Tumor necrosis factor-α inhibitor for successful treatment of toxic epidermal necrolysis with severe infection: a case series.肿瘤坏死因子-α抑制剂成功治疗合并严重感染的中毒性表皮坏死松解症:病例系列研究。
J Int Med Res. 2024 Jan;52(1):3000605231223059. doi: 10.1177/03000605231223059.
8
Positive experience with TNF-α inhibitor in toxic epidermal necrolysis resistant to high-dose systemic corticosteroids.肿瘤坏死因子-α抑制剂治疗大剂量全身糖皮质激素抵抗的中毒性表皮坏死松解症的阳性经验。
Front Med (Lausanne). 2023 Jul 24;10:1210026. doi: 10.3389/fmed.2023.1210026. eCollection 2023.
9
Biologic TNF-α Inhibitors for Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, and TEN-SJS Overlap: A Study-Level and Patient-Level Meta-Analysis.用于史蒂文斯-约翰逊综合征、中毒性表皮坏死松解症及中毒性表皮坏死松解症-史蒂文斯-约翰逊综合征重叠综合征的生物肿瘤坏死因子-α抑制剂:一项研究水平和患者水平的荟萃分析
Dermatol Ther (Heidelb). 2023 Jun;13(6):1305-1327. doi: 10.1007/s13555-023-00928-w. Epub 2023 May 13.
10
Etanercept leads to a rapid recovery of a Dabrafenib-/Trametinib-associated toxic epidermal necrolysis-like severe skin reaction.依那西普可使与达拉非尼/曲美替尼相关的中毒性表皮坏死松解症样严重皮肤反应迅速恢复。
Skin Health Dis. 2022 Nov 5;3(1):e185. doi: 10.1002/ski2.185. eCollection 2023 Feb.